Sponsor Pipeline

Rovi Pharmaceuticals Laboratories Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
1
Phase 3
1
Disease Areas
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-25 NCT06315205
Evaluation of the Pharmacokinetics, Safety, and Tolerability of IM Letrozole LEBE in…		 Trial completed
2026-07-21 NCT07401381
A Study to Compare the Steady-State Bioavailability of Injectable Letrozole SIE and Oral…		 Recruitment opened
Active Trials by Phase
Phase 3
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07340658 A Study to Investigate the Efficacy and Safety of Letrozole SIE Compared With Femara®… Advanced, Metastatic Breast Cancer Not Yet Recruiting
Phase 1
NCT07401381 A Study to Compare the Steady-State Bioavailability of Injectable Letrozole SIE and Oral… Hormone Receptor Positive Early Breast Cancer Recruiting
Disease Areas
Breast Cancer (2)
Get alerts when Rovi Pharmaceuticals Laboratories's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free